InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,836.05
(
-2.51%
)
Post# of 252501
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 120
Posts 20756
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: None

Monday, 04/10/2023 2:04:11 PM

Monday, April 10, 2023 2:04:11 PM

Post# of 252501
IgaN Nephropathy trials ....2 P 3 readouts / interims I'm aware of in 2023
This is the P 2 data from OMER ...pretty impressive
https://www.businesswire.com/news/home/20211105005398/en/Omeros-Announces-Results-From-Nearly-Three-Year-Follow-up-of-Patients-in-Phase-2-IgA-Nephropathy-Trial

Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up